HAAC has been negotiating with Schering to establish a compassionate use program that would provide ribavirin without Intron A. That program should start soon, but HAAC considers its eligibility criteria too restrictive. Under discussion, too, is a broader financial assistance program for uninsured patients. 1998 - Treatment Issues. Reproduced with permission. Inc. All rights reserved.
Noncommercial reproduction is encouraged.
Subscription lists are kept confidential. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only.